The real-life efficacy of methotrexate in vitiligo: A retrospective study and literature review. 2023

Reinhart Speeckaert, and Nanja van Geel
Department of Dermatology, Ghent University Hospital, Ghent, Belgium.

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014820 Vitiligo A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017496 Hypopigmentation A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections. Hypomelanosis,Hypomelanoses

Related Publications

Reinhart Speeckaert, and Nanja van Geel
January 2024, Journal of cutaneous medicine and surgery,
Reinhart Speeckaert, and Nanja van Geel
April 2023, Antibiotics (Basel, Switzerland),
Reinhart Speeckaert, and Nanja van Geel
May 2023, Journal of cosmetic dermatology,
Reinhart Speeckaert, and Nanja van Geel
May 1998, La Revue de medecine interne,
Reinhart Speeckaert, and Nanja van Geel
June 2007, Journal of the American Academy of Dermatology,
Reinhart Speeckaert, and Nanja van Geel
February 2019, Annales de dermatologie et de venereologie,
Reinhart Speeckaert, and Nanja van Geel
September 2019, Actas dermo-sifiliograficas,
Reinhart Speeckaert, and Nanja van Geel
December 1977, The British journal of dermatology,
Reinhart Speeckaert, and Nanja van Geel
June 2015, Journal of the European Academy of Dermatology and Venereology : JEADV,
Reinhart Speeckaert, and Nanja van Geel
September 2019, Dermatologic therapy,
Copied contents to your clipboard!